Zoonotic TB
Mycobacterium bovis causes zoonotic tuberculosis in humans, primarily transmitted from domestic animals. Preventive measures include controlling animal reservoirs, developing diagnostic tools, and strengthening surveillance systems.
Zoonotic tuberculosis (TB) is caused by Mycobacterium bovis, primarily transmitted from domestic animals like cattle. It poses a significant public health concern due to its potential transmission to humans through consumption of contaminated dairy products or direct contact with infected animals. Zoonotic TB can result in severe illness and economic losses, particularly in areas with close human-animal interaction. Control measures include surveillance in animal populations, pasteurization of dairy products, and strict hygiene practices. Collaborative efforts between veterinary and public health authorities are crucial to prevent zoonotic TB transmission and mitigate its impact on both human and animal health.
Related Conference of Zoonotic TB
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Zoonotic TB Conference Speakers
Recommended Sessions
- Asthma
- Atelectasis and Pneumothorax
- Cardiopulmonary Disease
- Chronic Obstructive Pulmonary Disease (COPD)
- Climate Change and Respiratory Diseases
- Epidemiology of TB Disease
- Gastroesophageal reflux disease (GERD)
- Latent TB Infection and Active TB Disease
- Lung Cancer: Screening, Diagnosis & Treatment
- Lung Function in Men with and without HIV
- Lung Infection
- Multidrug-resistant TB
- Mycobacterial Infections
- Palliative Care for Advanced Lung Cancer
- Pulmonary Complications of Endocrine Diseases
- Pulmonary Diseases and Therapeutics
- Pulmonary Edema
- TB Clinical Trials
- TB Diagnosis, Prevention & Treatment
- TB Vaccines
- TB-HIV Co-infections
- Zoonotic TB
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)